BIOMAT Database Logo BIOMAT Database Logo

[Beta-adrenergic inhibition and arterial hypertension]. 1985

A Simon, and J Levenson, and J Bouthier, and M Safar

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

A Simon, and J Levenson, and J Bouthier, and M Safar
[Beta adrenergic drugs in arterial hypertension].
July 1972, L'union medicale du Canada,
A Simon, and J Levenson, and J Bouthier, and M Safar
[Adrenergic beta receptor blockaders in arterial hypertension].
November 1975, Revista clinica espanola,
A Simon, and J Levenson, and J Bouthier, and M Safar
Cardiac performance and beta-adrenergic blockade in arterial hypertension.
January 1977, The American journal of the medical sciences,
A Simon, and J Levenson, and J Bouthier, and M Safar
[Hyperdynamic beta-adrenergic circulatory state with arterial hypertension].
June 1973, Revista clinica espanola,
A Simon, and J Levenson, and J Bouthier, and M Safar
[Beta adrenergic receptor blockade in the treatment of arterial hypertension].
January 1976, Kardiologia polska,
A Simon, and J Levenson, and J Bouthier, and M Safar
[Adrenergic beta receptor blockaders in the treatment of arterial hypertension].
November 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A Simon, and J Levenson, and J Bouthier, and M Safar
[Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
March 1978, Kardiologiia,
A Simon, and J Levenson, and J Bouthier, and M Safar
[Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
January 1977, La Prensa medica mexicana,
A Simon, and J Levenson, and J Bouthier, and M Safar
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
A Simon, and J Levenson, and J Bouthier, and M Safar
Effect of aptin, a beta-adrenergic blocking agent, in arterial hypertension.
November 1969, Acta medica Scandinavica,
Copied contents to your clipboard!